SNT 25.7% 4.4¢ syntara limited

takeover prospects, page-14

  1. 1,655 Posts.
    lightbulb Created with Sketch. 33
    SP could be back at $1 sooner than most think. QRX has bounced 100% in 6 months after being in a similar position to PXS. Anything positive from the March 18 FDA meeting or the soon expected trial results will do the trick. IMO this is way oversold now and a low risk buy at these low SP levels.
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.